INTRODUCTION
Alemtuzumab is an effective therapy for severe kidney transplant rejection. Yet, not all patients benefit from this treatment, while they are at risk for its toxic effects. A prediction model could help to identify these patients and potentially guide treatment decisions.
METHODS
We developed a predictio...
Lukas K. van Vugt, D. J. van den Broek, Pedro Miranda Afonso et al.· Immunobiology· 0 citations
BACKGROUND
Tacrolimus is the cornerstone of immunosuppressive treatment after kidney transplantation. Its application requires therapeutic drug monitoring, which is routinely performed by assessment of whole blood tacrolimus concentrations (WBTC) that largely comprises a pharmacologically inactive fraction. Monitoring...
J. Jonker, J. C. van den Born, D. Kremer et al.· American Society of Nephrolo...· 0 citations
BACKGROUND
CAR T cell therapy has revolutionized the treatment of hematological malignancies by effectively eliminating tumor cells. In the field of kidney transplantation, comparable cellular therapies are being explored to facilitate transplantation and prevent graft rejection. Chimeric HLA antibody receptor (CHAR) T...
Carolt Arana, I. Gille, R. Hagedoorn et al.· Journal of the American Soci...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.